Publication: The Effect of Managed Care on the Pharmaceutical Industry
Open/View Files
Date
1997
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
The Effect of Managed Care on the Pharmaceutical Industry (1997 Third Year Paper)
Research Data
Abstract
The pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing medicine, doctors practiced medicine without incentives to reduce the costs imposed on patients, their insurers, and the health care system. Most doctors practiced independently and were reimbursed for each service rendered by passive insurance companies. Shielded from the oversight of third-party intermediaries, doctors had financial incentives to provide more services, regardless of whether those services were therapeutically necessary.
Description
Other Available Sources
Keywords
Food and Drug Law, managed care, human drugs, pharmaceutical industry
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service